{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-23-022233","form_type":"8-K","ticker":"MED","cik":"0000910329","company_name":"MEDIFAST INC","filed_at":"2023-06-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.756185+00:00","generated_at":"2026-06-14T00:48:13.868724+00:00","sec_items":["5.07","8.01","9.01"],"event_type":"dividend","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Medifast declares $1.65 quarterly dividend payable Aug 8, 2023","bullets":["Quarterly cash dividend of $1.65 per share declared; payable Aug 8, 2023 to holders of record June 27, 2023.","All seven director nominees elected at June 14 annual meeting including Jeffrey J. Brown and Daniel R. Chard.","Stockholders approved advisory say-on-pay compensation and ratified RSM US as auditor for FY2023.","Advisory vote on executive compensation frequency set at one year as recommended by board."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-23-022233","json":"https://secwatch.observer/filing/0001628280-23-022233.json","markdown":"https://secwatch.observer/filing/0001628280-23-022233.md","text":"https://secwatch.observer/filing/0001628280-23-022233.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/910329/000162828023022233/0001628280-23-022233-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/910329/000162828023022233/med-20230614.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T00:48:13.868724+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"289eecc8711230d3ae59a1fe1c3c50af650d66e0","claim":"MEDIFAST INC shareholders approved Advisory vote on frequency of say-on-pay votes at the 2023-06-14 meeting.","evidence_excerpt":"The stockholders voted on a proposal to approve, on an advisory basis, a frequency of one-year of the advisory vote on executive compensation. The proposal was approved for an annual vote by a vote of the stockholders as follows: Once Every Year: 7,528,144 Once Every 2 Years: 36,611 Once Every 3 Years: 354,240 Abstained: 36,377 Broker Non-Votes: 1,059,865","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/910329/000162828023022233/0001628280-23-022233-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay frequency"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-14"}],"fact_type":"shareholder_vote"},{"claim_id":"4f2b44ea3dbf8c5724d341fbba1d0e6018328eb5","claim":"MEDIFAST INC shareholders approved Ratify appointment of RSM US LLP as Independent Registered Public Accounting Firm for fiscal year ending December 31, 2023 at the 2023-06-14 meeting.","evidence_excerpt":"The stockholders voted on a proposal to ratify the appointment of RSM US LLP as the Company’s Independent Registered Public Accounting Firm for the fiscal year ending December 31, 2023. The proposal was approved by a vote of stockholders as follows: For: 8,949,489 Against: 55,282 Abstained: 10,466","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/910329/000162828023022233/0001628280-23-022233-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-14"}],"fact_type":"shareholder_vote"},{"claim_id":"818a6c9117bff9c6f98050acb7781b4a77536c5a","claim":"MEDIFAST INC shareholders approved Advisory approval of named executive officer compensation at the 2023-06-14 meeting.","evidence_excerpt":"The stockholders voted on a proposal to approve, on an advisory basis, the compensation of the Company’s named executive officers as set forth in the proxy statement for the Annual Meeting. The proposal was approved by a vote of the stockholders as follows: For: 7,495,497 Against: 372,673 Abstained: 87,201 Broker Non-Votes: 1,059,866","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/910329/000162828023022233/0001628280-23-022233-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-14"}],"fact_type":"shareholder_vote"},{"claim_id":"dcfd11a8592f5ddf9ad4dde977c53f2f8a400e18","claim":"MEDIFAST INC shareholders approved Election of directors at the 2023-06-14 meeting.","evidence_excerpt":"The number of shares voted and broker non-votes for the directors nominated for re-election to the Board are set forth below. Director Name For Against Abstained Broker Non-Votes Jeffrey J. Brown 7,690,887 234,232 30,252 1,059,866 Daniel R. Chard 7,656,983 278,797 19,591 1,059,866 Elizabeth A. Geary 7,849,710 77,812 27,849 1,059,866 Michael A. Hoer 7,846,691 81,211 27,469 1,059,866 Scott Schlackman 7,810,395 117,616 27,360 1,059,866 Andrea B. Thomas 7,387,316 532,634 35,421 1,059,866 Ming Xian 7,542,094 385,088 28,189 1,059,866","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/910329/000162828023022233/0001628280-23-022233-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-14"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}